Somatostatin and Alzheimer's disease

Molecular and Cellular Endocrinology

Volumn 286, Issue 1-2, 2008, Pages 104-111

  Burgos Ramos, E ^a,b   Hervas Aguilar A ^a   Aguado Llera, D ^a   Puebla Jimenez L ^a   Hernandez Pinto A M ^a   Barrios, V ^b   Arilla Ferreiro, E ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Adenylyl cyclase; Alzheimer's disease; Amyloid beta peptide(25 35); Brain; Insulin like growth factor I; Neprilysin; Rat; Somatostatin; Somatostatin receptors

Indexed keywords

ADENYLATE CYCLASE; AMYLOID BETA PROTEIN[25-35]; MEMBRANE METALLOENDOPEPTIDASE; PROTEINASE; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 4;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; COGNITION; ENZYME ACTIVITY; NERVE CELL STIMULATION; NEUROMODULATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 43749091951     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.01.014     Document Type: Article

References (111)

1. D. Aguado-Llera E. Arilla-Ferreiro A. Campos-Barros L. Puebla-Jiménez V. Barrios Protective effects of insulin-like growth factor-I on the somatostatinergic system in the temporal cortex of (-amyloid-treated rats J. Neurochem. 92 2005 607 615
2. D. Aguado-Llera Arilla-Ferreiro J.A. Chowen J. Argente L. Puebla-Jiménez L.M. Frago V. Barrios 17β-estradiol protects depletion of rat temporal cortex somatostatinergic system by beta-amyloid Neurobiol. Aging 28 2007 1396 1409
3. C.G. Almeida R.H. Takahashi G.K. Gouras Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system J. Neurosci. 26 2006 4277 4288
4. H.K. Anandatheerthavarada G. Biswas M.A. Robin N.G. Avadhani Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells J. Cell. Biol. 161 2003 41 54
5. M.F. Beal M.F. Mazurek V.T. Tran G. Chattha E.D. Bird J.B. Martin Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease Science 229 1985 289 291
6. M.F. Beal M.F. Mazurek C.N. Svendsen E.D. Bird J.B. Martin Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease Ann. Neurol. 20 1986 489 495
7. L. Bergström A. Garlind L. Nilsson I. Alafuzoff C.J. Fowler B. Winblad R.F. Cowburn Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain J. Neurol. Sci. 105 1991 225 233
8. G. Bissette B. Myers Somatostatin in Alzheimer's disease and depression Life Sci. 51 1992 1389 1410
9. G. Bissette L. Cook W. Smith K.C. Dole B. Crain C.B. Nemeroff Regional neuropeptide pathology in Alzheimeŕs disease: corticotropin-releasing factor and somatostatin J. Alzheimers Dis. 1 1998 91 105
10. E. Bossy-Wetzel R. Schwarzenbacher S.A. Lipton Molecular pathways to neurodegeneration Nat. Med. 10 2004 S2 S9
11. H. Braak E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
12. E. Burgos-Ramos A. Hervás-Aguilar L. Puebla-Jiménez M.C. Boyano-Adánez E. Arilla-Ferreiro Chronic but not acute intracerebroventricular administration of amyloid (-peptide (25–35) decreases somatostatin content, adenylate cyclase activity, somatostatin-induced inhibition of adenylate cyclase activity and adenylate cyclase I levels in the rat hippocampus J. Neurosci. Res. 85 2007 433 442
13. A.I. Bush G. Multhaup R.D. Moir T.G. Williamson D.H. Small B. Rumble P. Pollwein K. Beyreuther C.L. Masters A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease J. Biol. Chem. 268 1993 16109 16112
14. A.I. Bush Copper, zinc, and the metallobiology of Alzheimer disease Alzheimer Dis. Assoc. Disord. 17 2003 147 150
15. R. Cacabelos H. Niigawa M.D. Rodríguez-Arnao A. Gomez-Pan T. Nishimura Influence of somatostatin and growth hormone-releasing factor on behaviour Horm. Res. 29 1988 129 132
16. E. Carro A. Núñez S. Busiguina I. Torres-Alemán Circulating insulin-like growth factor I mediates effects of exercise on the brain J. Neurosci. 20 2000 2926 2933
17. E. Carro J.L. Trejo T. Gómez-Isla D. LeRoith I. Torres-Alemán Serum insulin-like growth factor I regulates brain amyloid-beta levels Nat. Med. 8 2002 1390 1397
18. C.S. Casley J.M. Land M.A. Sharpe J.B. Clark M.R. Duchen L. Canevari Beta-amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons Neurobiol. Dis. 10 2002 258 267
19. C.W. Cotman W.W. Poon R.A. Rissman M. Blurton-Jones The role of caspase cleavage of tau in Alzheimer disease neuropathology J. Neuropathol. Exp. Neurol. 64 2005 104 112
20. R.F. Cowburn C. O’Neill R. Ravid I. Alafuzoff B. Winbland C.J. Fowler Adenylate cyclase activity in postmortem human brain: evidence of altered G protein mediation in Alzheimer's disease J. Neurochem. 58 1992 1409 1419
21. K.L. Davis M. Davidson R.K. Yang B.M. Davis L.J. Siever R.C. Mohs T. Ryan E. Coccaro L. Bierer S.D. Targum CSF somatostatin in Alzheimer's disease, depressed patients, and control subjects Biol. Psychiatry 24 1988 710 712
22. P. Davies R. Katzman R.D. Terry Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia Nature 288 1980 279 280
23. J. Dong C.S. Atwood V.E. Anderson S.L. Siedlak M.A. Smith G. Perry P.R. Carey Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence Biochemistry 42 2003 2768 2773
24. S. Doré S. Kar R. Quirion Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid and human amylin-induced toxicity Proc. Natl. Acad. Sci. U.S.A. 94 1997 4772 4777
25. P. Dournaud P. Dalaere J.J. Hauw J. Epelbaum Differential correlation between neurochemical deficits, neuropathology and cognitive status in Alzheimer's disease Neurobiol. Aging 16 1995 817 823
26. H. Dudek S.R. Datta T.F. Franke M.J. Birnbaum R. Yao G.M. Cooper R.A. Segal D.R. Kaplan M.E. Greenberg Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 1997 661 665
27. E.A. Eckman D.K. Reed C.B. Eckman Degradation of the Alzheimeŕs amyloid β peptide by endothelin-converting enzyme J. Biol. Chem. 276 2001 24540 24548
28. J. Epelbaum P. Dournaud M. Fodor C. Viollet The neurobiology of somatostatin Crit. Rev. Neurobiol. 8 1994 25 44
29. W. Farris S. Mansourian Y. Chang L. Lindsley E.A. Eckman M.P. Frosch C.B. Eckman R.E. Tanzi D.J. Selkoe S. Guenette Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo Proc. Natl. Acad. Sci. U.S.A. 100 2003 4162 4167
30. A. García-Jiménez J. Fastbom T.G. Ohm R.F. Cowburn G-protein alpha-subunit levels in hippocampus and entorhinal cortex of brains staged for Alzheimeŕs disease neurofibrillary and amyloid pathologies Neuroreport 14 2003 1523 1527
31. M.C. Ghigo A. Torsello R. Grilli M. Luoni M. Guidi S.G. Cella V. Locatelli E.E. Muller Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats J. Endocrinol. Invest. 20 1997 144 150
32. G. Gillies Somatostatin: the neuroendocrine story Trends Pharmacol. Sci. 18 1997 87 95
33. L. Gregori C. Fuchs M.E. Figueiredo-Pereira W.E. Van Nostrand D. Goldgaber Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro J. Biol. Chem. 270 1995 19702 19708
34. E. Hama T.C. Saido Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide Med. Hypotheses 65 2005 498 500
35. J. Harada M. Sugimoto Activation of caspase-3 in β-amyloid-induced apoptosis of cultured rat cortical neurons Brain Res. 842 1999 311 323
36. J.A. Hardy G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 1992 184 185
37. J.A. Hardy D.J. Selkoe The amyloid hypothesis of Alzheimeŕs disease: progress and problems on the road to therapeutics Science 297 2002 353 356
38. F. Hernández M. Díaz-Hernández J. Ávila J.J. Lucas Testing the ubiquitin-proteasome hypothesis of neurodegeneration in vivo Trends Neurosci. 27 2004 66 69
39. A. Hervás-Aguilar L. Puebla-Jiménez E. Burgos-Ramos D. Aguado-Llera E. Arilla-Ferreiro Effects of single and continuous administration of amyloid (-peptide (25–35) on adenylyl cyclase activity and the somatostatinergic system in the rat frontal and parietal cortex Neuroscience 135 2005 181 190
40. K. Hirai G. Aliev A. Nunomura H. Fujioka R.L. Russell C.S. Atwood A.B. Johnson Y. Kress H.V. Vinters M. Tabaton S. Shimohama A.D. Cash S.L. Siedlak P.L. Harris P.K. Jones R.B. Petersen G. Perry M.A. Smith Mitochondrial abnormalities in Alzheimer's disease J. Neurosci. 21 2001 3017 3023
41. K. Hsiao P. Chapman S. Nilsen C. Eckman Y. Harigaya S. Younkin F. Yang G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
42. 1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition Nat. Med. 6 2000 143 150
43. N. Iwata S. Tsubuki Y. Takaki K. Shirotani B. Lu N.P. Gerard C. Gerard E. Hama H.J. Lee T.C. Saido Metabolic regulation of brain Aβ by neprilysin Science 292 2001 1550 1552
44. N. Iwata Y. Takaki S. Fukami S. Tsubuki T.C. Saido Region-specific reduction of Aβ –degrading endopeptidase, neprilysin, in mouse hippocampus upon aging J. Neurosci. Res. 70 2002 493 500
45. N. Iwata H. Mizukami K. Shirotani Y. Takaki S. Muramatsu B. Lu N.P. Gerard C. Gerard K. Ozawa T.C. Saido Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain J. Neurosci. 24 2004 991 998
46. K.J. Ivins P.L. Thornton T.T. Rhon C.W. Cotman Neuronal apoptosis induced by β-amyloid is mediated by caspase-8 Neurobiol. Dis. 6 1999 440 449
47. O. Johansson T. Hoekfelt R.P. Elde Immunochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat Neuroscience 13 1984 265 339
48. J. Jordán M.F. Galindo R.J. Miller Role of calpain- and interleukin-1 beta converting enzyme-like proteases in the beta-amyloid-induced death of rat hippocampal neurons in culture J. Neurochem. 68 1997 1612 1621
49. A. Kamal A. Almenar-Queralt J.F. LeBlanc E.A. Roberts L.S. Goldstein Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP Nature 414 2001 646 648
50. K. Kato N. Kurobe F. Suzuki R. Marishita T. Asano T. Imagaki Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease J. Mol. Neurosci. 3 1991 95 99
51. N. Kimura S. Tomizawa K.N. Arai R.Y. Osamura N. Kimura Characterization of 5’-flanking region of rat somatostatin receptor sst2 gene: transcriptional regulatory elements and activation by Pitx1 and estrogen Endocrinology 142 2001 1427 1441
52. S. Krantic J. Robitaille R. Quirion Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimeŕs disease Brain Res. 573 1992 299 304
53. J. Kraus M. Wöltje N. Schönwetter V. Höllt Gene structure and regulation of the somatostatin receptor type 2 J. Physiol. 94 2000 199 204
54. 26]Aβ25-35/40) and fragment presence in the brains of Alzheimeŕs patients J. Neurosci. Res. 70 2002 474 483
55. U. Kumar Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimeŕs disease brain: an immunohistochemical analysis Neuroscience 134 2005 525 538
56. M.A. Leissring W. Farris A.Y. Chang D.M. Walsh X. Wu X. Sun M.P. Frosch D.J. Selkoe Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death Neuron 40 2003 1087 1093
57. S.A. Lipton Concept Turning down, but not off–Neuroprotection requires a paradigm shift in drug development Nature 428 2004 473 475
58. M.A. Lovell J.D. Robertson W.J. Teesdale J.L. Campbell W.R. Markesbery Copper, iron and zinc in Alzheimer's disease senile plaques J. Neurol. Sci. 158 1998 47 52
59. J.W. Lustbader M. Cirilli C. Lin H.W. Xu K. Takuma N. Wang C. Caspersen X. Chen S. Pollak M. Chaney F. Trinchese S. Liu F. Gunn-Moore L.F. Lue D.G. Walker P. Kuppusamy Z.L. Zewier O. Arancio D. Stern S.S. Yan H. Wu ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452
60. S.E. Molchan J.L. Hill R.A. Martínez B.A. Lawlor A.M. Mellow D.R. Rubinow G. Bissette C.B. Nemeroff T. Sunderland CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures Psychoneuroendocrinology 18 1993 509 519
61. L.N. Moller C.E. Stidsen B. Hartmann J.J. Holst Somatostatin receptors Biochim. Biophys. Acta 1616 2003 1 84
62. D.J. Moore V.L. Dawson T.M. Dawson Role for the ubiquitin-proteasome in Parkinson's disease and othe neurodegenerative brain amyloidoses Neuromol. Med. 4 2003 95 108
63. S. Nag B.K. Yee F. Tang Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and choline hippocampus of the rat after chronic intracerebroventricular infusion of β-amyloid (1–40) Brain Res. Bull. 50 1999 251 262
64. T. Nakagawa H. Zhu N. Morishima E. Li J. Xu B.A. Yankner J. Yuan Caspase-12 mediates endoplasmatic reticulum-specific apoptosis and cytotoxicity by amyloid-β Nature 403 2000 91 103
65. C.B. Nemeroff D.L. Knight G. Bissette Somatostatin: a neuropeptide system pathologically altered in Alzheimer's disease and depression Clin. Neuropharmacol. 15 1992 311A 312A
66. C.L. Nilsson A. Brinkmalm L. Minthon K. Blennow R. Ekman Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimeŕs disease and frontotemporal dementia Peptides 22 2001 2105 2112
67. S. Oh H.S. Hong E. Hwang H.J. Sim W. Lee S.J. Shin I. Mook-Jung Amyloid peptide attenuates the proteasome activity in neuronal cells Mech. Ageing Dev. 126 2005 1292 1299
68. T.G. Ohm J. Bohl B. Lemmer Reduced basal and stimulated (isoprenaline, Gpp(NH)p, forskolin) adenylate cyclase activity in Alzheimeŕs disease correlated with histopathological changes Brain Res. 540 1991 229 236
69. A. Olariu M.H. Tran K. Yamada M. Mizuno V. Hefco T. Nabeshima Memory deficits and increased emotionality induced by (-amyloid (25–35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus J. Neural. Transm. 108 2001 1065 1079
70. G. Olias C. Viollet H. Kusserow J. Epelbaum W. Meyerhof Regulation and function of somatostatin receptors J. Neurochem. 89 2004 1057 1091
71. C. O’Neill B. Wiehager C.J. Fowler R. Ravid B. Winblad R.F. Cowburn Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain Brain Res. 636 1994 193 201
72. R.Z. Orlowski The role of ubiquitin-proteasome pathway in apoptosis Cell. Death Differ. 6 1999 303 313
73. R. Panetta Y.C. Patel Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors Life Sci. 56 1995 333 342
74. Y.C. Patel Somatostatin and its receptor family Front. Neuroendocrinol. 20 1999 157 198
75. Y.C. Patel M.T. Greenwood R. Panetta L. Demchyshyn H. Niznik C.B. Srikant The somatostatin receptor family Life Sci. 57 1995 1249 1265
76. G. Pigino G. Morfini A. Pelsman M.P. Mattsonm S.T. Brady J. Busciglio Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport J. Neurosci. 23 2003 4499 4508
77. C.J. Pike D. Brudick A.J. Walencevicz C.G. Glab C.W. Cotman Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state J. Neurosci. 13 1993 1676 1687
78. B. Ramos D. Baglietto-Vargas J.C. del Rio I. Moreno-Gonzalez C. Santa-Maria S. Jiménez C. Caballero J.F. Lopez-Tellez Z.U. Khan D. Ruano A. Gutierrez J. Vitorica Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1 × APP transgenic model of Alzheimer's disease Neurobiol. Aging 27 2006 1658 1672
79. S. Reichlin Somatostatin N. Engl. J. Med. 309 1983 1495 1501
80. R.R. Reinhardt C.A. Bondy Insulin-like growth factors cross the blood-brain barrier Endocrinology 135 1994 1753 1761
81. J. Ryder Y. Su B. Ni Akt/GSK3beta serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations Cell Signal 16 2004 187 200
82. 42 through modulation of proteolytic degradation Nat. Med. 11 2005 434 439
83. K. Sambamurti N.H. Greig D.K. Lahiri Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease Neuromol. Med. 1 2002 1 31
84. D. Scheuner C. Eckman M. Jensen X. Song M. Citron N. Suzuki T.D. Bird J. Hardy M. Hutton W. Kukull E. Larson E. Levy-Lahad M. Viitanen E. Peskind P. Poorkaj G. Schellenberg R. Tanzi W. Wasco L. Lannfelt D. Selkoe S. Younkin Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Nat. Med. 2 1996 864 870
85. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
86. K. Shirotani S. Tsubuki N. Iwata Y. Takaki W. Harigaya K. Maruyama S. Kiryu-Seo H. Kiyama H. Iwata T. Tomita T. Iwatsubo T.C. Saido Neprilysin degrades both amyloid b peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases J. Biol. Chem. 276 2001 21895 21901
87. D.J. Selkoe Amyloid β-protein and the genetics of Alzheimer's disease J. Biol. Chem. 271 1996 18295 18298
88. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
89. G. Sorrentino V. Bonavita Neurodegenerative and Alzheimer's disease: The lesson from tautopathies Neurol. Sci. 28 2007 63 71
90. M.Y. Stepanichev M.V. Onufriev O.S. Mitrokhina Y.V. Moiseeva N.A. Lazareva I.V. Victorov Neurochemical, behavioural and neuromorphological effects of central administration of β-amyloid peptide (25–35) in rat Neurochemistry 17 2000 291 306
91. M.Y. Stepanichev Y.V. Moiseeva N.A. Lazareva M.V. Onufriev N.V. Gulyaeva Single intracerebroventricualr administration of amyloid-beta (25–35) peptide induces impairment in short-term rather than long-term memory in rats Brain Res. Bull. 61 2003 197 205
92. W.F. Stewart C. Kawas M. Corrada E.J. Metter Risk of Alzheimer's disease and duration of NSAID use Neurobiology 48 1997 626 632
93. R.K. Sunahara R. Taussig Isoforms of mammalian adenylate cyclase: multiplicities of signaling Mol. Intervent. 2 2002 168 184
94. C.M. Troy S.A. Rabacchi W.J. Friedman T.F. Frappier K. Brown M.L. helanski Caspase-2 mediates neuronal cell death induced by β-amyloid J. Neurosci. 20 2000 1386 1392
95. Tseng, B.P., Green, K.N., Chan, J.L., Blurton-Jones, M., LaFerla, F.M., 2007. Aβ inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging, in press.
96. A.J. Turner N.N. Nalivaeva New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection Int. Rev. Neurobiol. 82 2007 113 135
97. M. Vanetti M. Kouba X. Wang G. Vogt V. Hollt Cloning and expression of a novel mouse somatostatin receptor (SSTR2B) FEBS Lett. 311 1992 290 294
98. M. Vanetti G. Vogt V. Hollt The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization FEBS Lett. 331 1993 260 266
99. L. Vécsei I. Bollok G. Telegdy Phenoxybenzamine antagonizes somatostatin-induced anti-amnesia in rats Eur. J. Pharmacol. 99 1984 325 328
100. L. Vécsei P. Klivenyi Somatostatin and Alzheimeŕs disease Arch. Gerontol. Geriat. 21 1995 35 41
101. S. Weggen M. Rogers J. Eriksen NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends Pharmacol. Sci. 28 2007 536 543
102. W. Wei X. Wang J.W. Kusiak Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection J. Biol. Chem. 277 2002 17649 17656
103. M.F. Weiner D. Svetlik R.C. Risser What depressive symptoms are reported in Alzheimer's patients? Int. J. Geriatr. Psychiatry 12 1997 648 652
104. C.A. Whitford J.M. Candy J.A. Edwardson R.H. Perry Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's disease J. Neurol. Sci. 86 1988 130 138
105. M. Yamada K. Tanabe K. Wada K. Shimoke Y. Ishikawa T. Ikeuchi S. Koizumi H. Hatanaka Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-I in cultured cerebral cortical neurons J. Neurochem. 78 2001 940 951
106. Y. Yamaguchi S. Kawashima Effects of amyloid-β-(25–35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat Eur. J. Pharmacol. 412 2001 265 272
107. 2-induced apoptosis of PC12 cells independent of ceramide formation Neurol. Res. 22 2000 556 564
108. M. Yamamoto H. Ozawa T. Saito S. Hatta P. Riederer N. Takahata Ca2+/CaM-sensitive adenylate cyclase activity is decreased in the Alzheimeŕs brain: possible relation to type I adenylate cyclase J. Neural. Transm. 104 1997 721 732
109. M. Yamamoto M.E. Gotz H. Ozawa C. Luckhaus T. Saito M. Rosler P. Riederer Hippocampal level of neural specific adenylate cyclase type I is decreased in Alzheimeŕs disease Biochim. Biophys. Acta 1535 2000 60 68
110. K. Yasojima H. Akiyama E.G. McGeer P.L. McGeer Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide Neurosci. Lett. 297 2001 97 100
111. W.H. Zheng R. Quirion Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival J. Neurochem. 89 2004 844 852